-
Clinical use and future requirements of relative biological effectiveness: survey among all european proton therapy centres
Authors:
Lena Heuchel,
Christian Hahn,
Jörg Pawelke,
Brita Singers Sørensen,
Manjit Dosanjh,
Armin Lühr
Abstract:
Background and purpose: The relative biological effectiveness (RBE) varies along the treatment field. However, in clinical practice, a constant RBE of 1.1 is assumed, which can result in undesirable side effects. This study provides an accurate overview of current clinical practice for considering proton RBE in Europe. Materials and Methods: A survey was devised and sent to all proton therapy cent…
▽ More
Background and purpose: The relative biological effectiveness (RBE) varies along the treatment field. However, in clinical practice, a constant RBE of 1.1 is assumed, which can result in undesirable side effects. This study provides an accurate overview of current clinical practice for considering proton RBE in Europe. Materials and Methods: A survey was devised and sent to all proton therapy centres in Europe that treat patients. The online questionnaire consisted of 39 questions addressing various aspects of RBE consideration in clinical practice, including treatment planning, patient follow-up and future demands. Results: All 25 proton therapy centres responded. All centres prescribed a constant RBE of 1.1, but also applied measures (except for one eye treatment centre) to counteract variable RBE effects such as avoiding beams stop** inside or in front of an organ at risk and putting restrictions on the minimum number and opening angle of incident beams for certain treatment sites. For the future, most centres (16) asked for more retrospective or prospective outcome studies investigating the potential effect of the effect of a variable RBE. To perform such studies, 18 centres asked for LET and RBE calculation and visualisation tools developed by treatment planning system vendors. Conclusion: All European proton centres are aware of RBE variability but comply with current guidelines of prescribing a constant RBE. However, they actively mitigate uncertainty and risk of side effects resulting from increased RBE by applying measures and restrictions during treatment planning. To change RBE-related clinical guidelines in the future more clinical data on RBE are explicitly demanded.
△ Less
Submitted 30 May, 2022;
originally announced May 2022.
-
Does FLASH deplete Oxygen? Experimental Evaluation for Photons, Protons and Carbon Ions
Authors:
Jeannette Jansen,
Jan Knoll,
Elke Beyreuther,
Jörg Pawelke,
Raphael Skuza,
Rachel Hanley,
Stephan Brons,
Francesca Pagliari,
Joao Seco
Abstract:
Purpose: To investigate experimentally, if FLASH irradiation depletes oxygen within water for different radiation types such as photons, protons and carbon ions.
Methods: This study presents measurements of the oxygen consumption in sealed, 3D printed water phantoms during irradiation with X-rays, protons and carbon ions at varying dose rates up to 340 Gy/s. The oxygen measurement was performed…
▽ More
Purpose: To investigate experimentally, if FLASH irradiation depletes oxygen within water for different radiation types such as photons, protons and carbon ions.
Methods: This study presents measurements of the oxygen consumption in sealed, 3D printed water phantoms during irradiation with X-rays, protons and carbon ions at varying dose rates up to 340 Gy/s. The oxygen measurement was performed using an optical sensor allowing for non-invasive measurements.
Results: Oxygen consumption in water only depends on dose, dose rate and linear energy transfer (LET) of the irradiation. The total amount of oxygen depleted per 10 Gy was found to be 0.04 - 0.18 % atm for 225 kV photons, 0.04 - 0.25 % atm for 224 MeV protons and 0.09 - 0.17 % atm for carbon ions. consumption depends on dose rate by an inverse power law and saturates for higher dose rates because of self-interactions of radicals. Higher dose rates yield lower oxygen consumption. No total depletion of oxygen was found for clinical doses.
Conclusions: FLASH irradiation does consume oxygen, but not enough to deplete all the oxygen present. For higher dose rates, less oxygen was consumed than at standard radiotherapy dose rates. No total depletion was found for any of the analyzed radiation types for 10 Gy dose delivery using FLASH.
△ Less
Submitted 1 March, 2021; v1 submitted 25 February, 2021;
originally announced February 2021.
-
Map** the Future of Particle Radiobiology in Europe: The INSPIRE Project
Authors:
N. T. Henthorn,
O. Sokol,
M. Durante,
L. De Marzi,
F. Pouzoulet,
J. Miszczyk,
P. Olko,
S. Brandenburg,
M-J. van Goethem,
L. Barazzuol,
M. Tambas,
J. A. Langendijk,
M. Davidkova,
V. Vondravcek,
E. Bodenstein,
J. Pawelke,
A. Lomax,
D. C. Weber,
A. Dasu,
B. Stenerlow,
P. R. Poulsen,
B. S. Sorensen,
C. Grau,
M. K. Sitarz,
A-C Heuskin
, et al. (5 additional authors not shown)
Abstract:
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a number of unanswered questions considering differences in the biological response between particles and photons. These questions, and probing of biological mechanisms in general, necessitate experimental investigation. The Infrastructure in Proton International Research (INSPIRE) project was created t…
▽ More
Particle therapy is a growing cancer treatment modality worldwide. However, there still remains a number of unanswered questions considering differences in the biological response between particles and photons. These questions, and probing of biological mechanisms in general, necessitate experimental investigation. The Infrastructure in Proton International Research (INSPIRE) project was created to provide an infrastructure for European research, unify research efforts on the topic of proton and ion therapy across Europe, and to facilitate the sharing of information and resources. This work highlights the radiobiological capabilities of the INSPIRE partners, providing details of physics (available particle types and energies), biology (sample preparation and post-irradiation analysis), and researcher access (the process of applying for beam time). The collection of information reported here is designed to provide researchers both in Europe and worldwide with the tools required to select the optimal center for their research needs. We also highlight areas of redundancy in capabilities and suggest areas for future investment.
△ Less
Submitted 7 July, 2020;
originally announced July 2020.
-
Spectral and spatial sha** of laser-driven proton beams using a pulsed high-field magnet beamline
Authors:
Florian-Emanuel Brack,
Florian Kroll,
Lennart Gaus,
Constantin Bernert,
Elke Beyreuther,
Thomas E. Cowan,
Leonhard Karsch,
Stephan Kraft,
Leoni A. Kunz-Schughart,
Elisabeth Lessmann,
Josefine Metzkes-Ng,
Lieselotte Obst-Hübl,
Jörg Pawelke,
Martin Rehwald,
Hans-Peter Schlenvoigt,
Ulrich Schramm,
Manfred Sobiella,
Emília Rita Szabó,
Tim Ziegler,
Karl Zeil
Abstract:
Intense laser-driven proton pulses, inherently broadband and highly divergent, pose a challenge to established beamline concepts on the path to application-adapted irradiation field formation, particularly for 3D. Here we experimentally show the successful implementation of a highly efficient (50% transmission) and tuneable dual pulsed solenoid setup to generate a homogeneous (8.5% uniformity late…
▽ More
Intense laser-driven proton pulses, inherently broadband and highly divergent, pose a challenge to established beamline concepts on the path to application-adapted irradiation field formation, particularly for 3D. Here we experimentally show the successful implementation of a highly efficient (50% transmission) and tuneable dual pulsed solenoid setup to generate a homogeneous (8.5% uniformity laterally and in depth) volumetric dose distribution (cylindrical volume of 5 mm diameter and depth) at a single pulse dose of 0.7 Gy via multi-energy slice selection from the broad input spectrum. The experiments have been conducted at the Petawatt beam of the Dresden Laser Acceleration Source Draco and were aided by a predictive simulation model verified by proton transport studies. With the characterised beamline we investigated manipulation and matching of lateral and depth dose profiles to various desired applications and targets. Using a specifically adapted dose profile, we successfully performed first proof-of-concept laser-driven proton irradiation studies of volumetric in-vivo normal tissue (zebrafish embryos) and in-vitro tumour tissue (SAS spheroids) samples.
△ Less
Submitted 6 April, 2020; v1 submitted 18 October, 2019;
originally announced October 2019.
